Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City

Author(s):
Mahnaz TashakoriMahnaz Tashakori1, Ahmad JamalizadehAhmad Jamalizadeh2, Mohsen Nejad-GhaderiMohsen Nejad-Ghaderi2, Maryam HadaviMaryam Hadavi3, Aliakbar Yousefi-AhmadipourAliakbar Yousefi-Ahmadipour1, fatemeh mohseni moghadamfatemeh mohseni moghadam1, Athareh SoresrafilAthareh Soresrafil1, mashayekhi mashayekhimashayekhi mashayekhi4,*
1Department of Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2Non-communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
3Department of Anesthesiology, Paramedical School, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
4Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Journal of Inflammatory Diseases:Vol. 25, issue 4; 203-210
Published online:Mar 31, 2022
Article type:Research Article
How to Cite:Tashakori M, Jamalizadeh A, Nejad-Ghaderi M, Hadavi M, Yousefi-Ahmadipour A, et al. Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City. J Inflamm Dis. 2024;25(4):e156295. doi:

Abstract

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles